Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aussie HIV/AIDS Groups Protest Coverage Delays For Hepatitis B Tests

This article was originally published in PharmAsia News

Executive Summary

HIV/AIDS groups in Australia accuse the federal government of unnecessarily delaying for at least six years approval of coverage for a diagnostic for hepatitis B. The government relies on its Medical Services Advisory Committee to recommend federal funding for medical procedures based on their safety and effectiveness. Recently the HIV/AIDS and other groups have complained about the panel's lack of accountability for its approvals process. The HIV/AIDS groups noted it took three years to approve a procedure for determining a patient's hepatitis B viral load because the panel lost paperwork. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072443

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel